Ketamine administration for acute painful sickle cell crisis: A randomized controlled trial

OBJECTIVE: The objective was to evaluate the efficacy and safety of single‐dose ketamine infusion in adults with sickle cell disease (SCD) who presented with acute sickle vasoocclusive crisis (VOC). METHODS: This study was a parallel‐group, prospective, randomized, double‐blind, pragmatic trial. Par...

Descripción completa

Detalles Bibliográficos
Autores principales: Alshahrani, Mohammed S., AlSulaibikh, Amal H., ElTahan, Mohamed R., AlFaraj, Sukayna Z., Asonto, Laila P., AlMulhim, Abdullah A., AlAbbad, Murad F., Almaghraby, Nisreen, AlJumaan, Mohammed A., AlJunaid, Thamir O., Darweesh, Moath N., AlHawaj, Faisal M., Mahmoud, Alaa M., Alossaimi, Bader K., Alotaibi, Shaikhah K., AlMutairi, Talal M., AlSulaiman PharmD, Duaa A., Alfaraj, Dunya, Alhawwas, Reem, Mbuagbaw, Lawrence, Lewis, Kim, Verhovsek, Madeleine, Crowther, Mark, Guyatt, Gordon, Alhazzani, Waleed
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Original Contributions
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9292870/
https://www.ncbi.nlm.nih.gov/pubmed/34449939
http://dx.doi.org/10.1111/acem.14382

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9292870/
https://www.ncbi.nlm.nih.gov/pubmed/34449939
http://dx.doi.org/10.1111/acem.14382

Ejemplares similares